A large cohort study of patients with psoriasis using wearable devices finds more exercise is associated with a lower risk ...

A new trial finds guselkumab is highly effective and well tolerated for moderate to severe scalp psoriasis in individuals ...

Guselkumab and risankizumab for psoriasis have the highest rates of drug survival among biologics measured and a comparable safety profile.

Treatment with TNF inhibitors may be beneficial over phototherapy in reducing the risk for psoriatic arthritis in patients ...

Medically reviewed by Katlein Franca, MD Guttate psoriasis causes small, round bumps. It's typically triggered by a Streptococcus (strep) bacteria infection. Guttate psoriasis most commonly affects ...

Is the Esprit Turbo some kind of automotive Bermuda Triangle? Does it throw sane men com­pletely out of calibration? Does it invali­date the laws of common sense? Does it re­lieve the heartbreak of ...

Incidences of malignant neoplasms were low and stable with long-term ixekizumab treatment for people with psoriatic disease ...

Some medicines used for heart problems, like beta-blockers, ACE inhibitors, and calcium channel blockers, have been known to ...

This segment is sponsored by Arcutis Biotherapeutics.Nearly 9 million people in the U.S. have an inflammatory skin condition ...

Patients with psoriatic arthritis who meet clinical criteria for minimal disease activity also tend to report good disease ...

Psoriasis With a Side of Arthritis Biologics also represent the first choice of systemic therapy for Oyetewa Asempa, MD, of Baylor College of Medicine in Houston.

Despite recent significant advances in systemic therapies for psoriasis, topical treatment retains a prominent role for many patients. The American Academy of Dermatology/National Psoriasis ...